Mercaptopurine 50 mg [Purinethol]
RxNorm 567599
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 567599 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: mercaptopurine 50 mg [Purinethol].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDC
Semantic Branded Drug Component (SBDC):
Mercaptopurine 50 mg [Purinethol]
(Atom ID: 3501201)
Patient Education
Mercaptopurine
Mercaptopurine is used alone or with other chemotherapy drugs to treat acute lymphocytic leukemia (ALL; also called acute lymphoblastic leukemia and acute lymphatic leukemia; a type of cancer that begins in the white blood cells). Mercaptopurine is in a class of medications called purine antagonists. It works by stopping the growth of cancer cells.
[Learn More]
* Please review the disclaimer below.